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ABSTRACT
Background. We aimed to determine the prevalence of vaginal colonization by
Gardnerella vaginalis and of bacterial vaginosis (BV) in Portuguese pregnant women,
and to identify risk factors for BV and G. vaginalis colonization in pregnancy.
Methods. A cross-sectional study was conducted among pregnant women aged ≥ 18
years who were attending in two public hospitals of the Northwest region of Portugal.
Epidemiological data was collected by anonymous questionnaire. BV was diagnosed by
Nugent criteria and G. vaginalis presence was identified by polymerase chain reaction.
Crude associations between the study variables and BV or G. vaginalis colonization
were quantified by odds ratios (ORs) and their 95% confidence intervals (CIs).
Results. The prevalences of BV and of G. vaginalis colonization among Portuguese
pregnant women were 3.88% and 67.48%, respectively. Previous preterm delivery
and colonization by G. vaginalis were factors with very high OR, but only statistically
significant for a 90% CI. Conversely, higher rates of G. vaginalis colonization were
found in women with basic educational level (OR= 2.77, 95% CI [1.33–5.78]), during
the second trimester of pregnancy (OR= 6.12, 95%CI [1.80–20.85]) and with BV flora
(OR = 8.73, 95% CI [0.50–153.60]).
Discussion. Despite the lower number of women with BV, prevalence ratios and
association with risk factors were similar to recent European studies. However, the
percentage of healthy women colonized by G. vaginalis was significantly higher than
many previous studies, confirming that G. vaginalis colonization does not always lead
to BV development.
Subjects Epidemiology, Gynecology and Obstetrics, Infectious Diseases, Women’s Health
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INTRODUCTION
Worldwide, bacterial vaginosis (BV) is considered to be one of the most prevalent gyneco-
logical disorders of reproductive-age women and one of themost common causes of vaginal
symptoms, prompting women to seek medical care (Sobel, 1997). This vaginal infection is
microbiologically characterized by the replacement of a Lactobacillus-dominated vaginal
microbiota by variable mixtures of strictly and facultative anaerobic bacteria including
Gardnerella vaginalis, Atopobium vaginae and Mobiluncus spp. (Verhelst et al., 2004).
Currently, the presence of BV during pregnancy has attracted the attention of both
clinicians and the scientific community, due to its relation with adverse pregnancy
consequences such as preterm delivery (Leitich et al., 2003) and miscarriage (Leitich & Kiss,
2007). The mechanisms involved in pregnancy complications induced by BV are not fully
clarified, but many researchers suggest that preterm delivery results from bacteria ascension
from vagina to the membranes and amniotic fluid (Goldenberg, Hauth & Andrews, 2000;
Pararas, Skevaki & Kafetzis, 2006). In recent years, several studies demonstrated that the
presence or high load of vaginal microbes associated to BV such as G. vaginalis, A. vaginae,
Mobiluncus spp., Mycoplasma spp. and Leptotrichia/Sneathia species, were related with an
increased risk of preterm birth (Foxman et al., 2014; Nelson et al., 2014; Bretelle et al., 2015;
Kuon et al., 2017). However, the great diversity of vaginal microbiota in women with BV
affects its potential to develop preterm birth and other negative outcomes in pregnancy
(Hyman et al., 2014;Nelson et al., 2015) and it becomes BV treatment in pregnant women a
challenging task (Haahr et al., 2016). Despite of its high impact, few epidemiological studies
on BV have been conducted in Portugal (Guerreiro, Gigante & Teles, 1998; Silva et al., 2014;
Machado et al., 2015). Specifically, there is no information related to the prevalence of BV
among Portuguese pregnant women. As such, we set this first epidemiological study aimed
to determine the prevalences of BV and of G. vaginalis vaginal colonization in Portuguese
pregnant women.
MATERIALS & METHODS
Population, data and biological samples collection
This cross-sectional study involved pregnant women attending prenatal care consultations
in two public Portuguese hospitals of the Northwest region (Hospital of Braga and Unidade
Local de Saúde deMatosinhos), betweenMay 2014 andMay 2016. The inclusion criteria for
the present study were: to be pregnant at any gestational age and to be older than 18 years.
The exclusion criteria were: women who were unable to read or understand Portuguese
and who did not accept to participate in study.
During prenatal care consultation, obstetricians invited all eligible women under their
care to participate in the study. All participants signed the informed consent form, as
approved by the respective local ethical committees. Afterwards, the participants were
questioned by the obstetricians about their age, educational level (basic, secondary or
university), if they had previous BV episodes, previous deliveries, history of preterm
delivery, suffered of chronic disease or smoking and about its use of intimate hygienic
products and vitamin supplements, and determined the current gestational period (first,
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second or third trimester). A short standardized questionnaire was used to collect these
data. Finally, the obstetricians collected vaginal samples (only one sample point was taken
for each participant), using sterile swab containing Amies transport medium with coal
(VWR, Radnor, PA, USA). After collection, the swabs were immediately conserved at
4 ◦C and transported to the Laboratory of Research in Biofilms Rosário Oliveira of the
University of Minho, where they were processed.
Gram staining and BV diagnosis
For BV diagnosis, a direct smear was performed by transferring the vaginal fluid present on
the swab to a glass slide. Then, vaginal smears were heat-fixed and Gram stained (Spiegel,
Amsel & Holmes, 1983). Afterwards, the smears were visualized using an Olympus BX51
microscope (Olympus Portugal SA, Lisboa, Portugal) under oil immersion objective
(1,000× magnification) and, subsequently, graded in accordance with the Nugent
scoring system (Nugent, Krohn & Hillier, 1991). In summary, on 10 microscopic fields,
the following bacterial morphotypes were identified and quantified: large gram-positive
rods (Lactobacillus spp.), small gram-variable rods (G. vaginalis), small gram-negative rods
(Bacteroides spp.) and curved gram-variable rods (Mobiluncus spp.). The sum of each
morphotype score allowed to classify vaginal flora into normal (score 0–3), intermediate
(score 4–6) or BV (score 7–10).
Molecular detection of G. vaginalis
Each vaginal swab was then immersed in 2 mL of 0.9% (wt/v) of sodium chloride
(Liofilchem; Roseto degli Abruzzi, Italy) and the content was suspended using vigorous
vortexing. Afterwards, 1.5 mL of each diluted swab content was transferred into a tube
that was centrifuged at 8,000 rpm, during 10 s, in order to allow for coal deposition at
the bottom of the tube. Then, 0.6 mL of supernatant was collected to a new tube and
this later was centrifuged at 13,500 rpm, during 5 min. At the end, the supernatant was
discarded and the pellet was suspended in 0.1 mL of sterile ultra-pure water. This bacterial
suspension was incubated in a heating block at 95 ◦C for 20 min in order to disrupt
bacterial cell wall and release the cell content, making available the genomic DNA that
is required for polymerase chain reaction (PCR). After incubation, it was immediately
cooled on ice for 5 min and the cell suspension was centrifuged at 13,500 rpm, during
5 min. The supernatant was used as template for a multiplex PCR since we used the PCR
to amplify different DNA sequences simultaneously (namely gene encoding 16S rRNA of
G. vaginalis and aap gene of Staphylococcus epidermidis). Briefly, each PCR included 6 µL
of Dream Taq PCR Master Mix 2X (Thermo Fisher Scientific, Waltham, MA, USA), 1 µL
of DNA from the vaginal sample, 2 µL of distilled water DNase/RNAse free (Thermo Fisher
Scientific), 0.5 µL of 5 µM forward (FW1) G. vaginalis primer , 0.5 µL of 5 µM reverse
(RV1) G. vaginalis primer, 0.5 µL of 5 µM FW S. epidermidis primer, 0.5 µL of 5 µM RV
S. epidermidis primer and 1 µL of complementary DNA of S. epidermidis. Also, a negative
control (containing 1 µL of DNase/RNase free water instead of genomic DNA) and positive
control (containing 1 µL of genomic DNA from pure culture ofG. vaginalis) were included
in each set of reactions. The tubes were placed in a thermocycler (Bio-Rad; Hercules, CA,
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Table 1 Primers used in this study.
Target Set Sequence (5′–3′) TM
(◦ C)
Amplification region
(GenBank)
Reference
FW1 CTCTTGGAAACGGGTGGTAA 60
RV1 TTGCTCCCAATCAAAAGCGGT 62
KP996686.1
(from 99 to 399)
Henriques et al.
(2012)
FW2 AGCCTAGGTGGGCCATTACC 59
G. vaginalis
16SRNA
RV2 TGAGTAATGCGTGACCAACC 55
KP996686.1
(from 206 to 373)
Castro et al. (2017)
FW GCACCAGCTGTTGTTGTACC 59S. epidermidis
aap RV GCATGCCTGCTGATAGTTCA 60
CP020463.1 (from
11,0863 to 11,1053)
Franc¸a et al. (2012)
Notes.
TM, melting temperature; FW, forward; RV, reverse.
USA) that was programmed with the following protocol: 94 ◦C for 2 min, 40 steps of 94 ◦C
for 30 s, 60 ◦C for 30 s, 72 ◦C for 1 min and finally 72 ◦C for 5 min. The inclusion of the
specific primers for the S. epidermidis aap gene acted as internal positive control of PCR
procedure, in order to ensure that amplifiable DNA was successfully extracted and there
are no PCR inhibitors on sample.
After the PCR reaction, amplified products were analyzed in 1% (wt/v) of agarose
(SeaKem LE; Rockland, ME, USA) gel with 0.05 µL/mL midori green nucleic acid dye
(Nippon Genetics Europe GmbH, Düren, Germany). The electrophoresis run for 50 min
at 100 volts. Finally, the results were visualized using the ChemiDoc (Bio-Rad) system,
according to the manufacturer’s instructions. Negative results for the amplification of
the gene encoding 16S rRNA of G. vaginalis were confirmed using an independent set of
primers (FW2/RV2). All primers used are described in Table 1 and were previously assessed
for specificity (Franc¸a et al., 2012; Henriques et al., 2012; Castro et al., 2017).
Statistical analysis
Data were analyzed with GraphPad Prism version 6 (GraphPad Software Inc., La Jolla,
CA, USA). Firstly, we determined BV and G. vaginalis colonization prevalences and
then we used Chi-square or Fisher’s exact test to verify whether BV positive status
or G. vaginalis colonization were associated with some sociodemographic, medical,
reproductive, behavioral ormicrobiological variables. A p-value <0.05was used as threshold
for statistically significance. The strength of association betweenBVdiagnosis orG. vaginalis
colonization with the study variables was assessed through calculation of odds ratios (OR)
and their 95% confidence intervals (CI).
Ethical considerations
The study was approved by the ethics committees of Unidade Local de Saúde deMatosinhos
(process 013/CE/JAS) and of Hospital of Braga (process SECVS 063/2014). All the study
participants agreed through informed consent to collaborate voluntarily, anonymously
and freely. To ensure confidentiality no personal data were recorded that could lead to
identification of the participants.
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Table 2 Characteristics of the studied population (n= 206).
Variables (%)
Sociodemographic
Age (mean± SD, years) 30.00± 5.16
<30 years 41.75
≥30 years 58.25
Educational level
≤Basic 29.13
Secondary 35.44
≥University 35.44
Medical
Previous BV 7.77
History of chronic disease 14.56
Reproductive
Previous delivery 41.75
Previous preterm delivery 6.80
Pregnancy trimester
First 11.65
Second 16.50
Third 71.84
Behavioral
Tobacco consumption 12.62
Use of intimate hygiene products 28.64
Vitamin supplementation 86.41
Notes.
SD, standard deviation; BV, bacterial vaginosis.
Values are given as mean± SD or percentage (%).
RESULTS
Between May 2014 and May 2016, a total of 273 women followed in prenatal care
consultation of two public Portuguese hospitals of the Northwest region agreed to
participate in the current study. Among them, 67 had uninterpretable Gram-staining slides
and where excluded from this study. Table 2 summarizes sociodemographic, medical,
reproductive and behavioral characteristics of the studied population (n= 206). The
participants had ages comprised between 19 and 41 years, resulting in mean age of 30.00
± 5.16 years. Moreover, the majority of participants was in the third trimester of pregnancy
(71.84%) and used vitamin supplementation (86.41%).
Among the 206 pregnant women, BV was diagnosed in only eight participants, resulting
in a BV prevalence of 3.88% (Table 3). Probably due to the low number of BV cases,
we did not found any significant statistically association between BV and the risk factors
considered in this study (p-value > 0.05). Nevertheless, previous preterm delivery and
colonization by G. vaginalis were factors with very high OR, that could be considered
statistically significant for a 90% CI.
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Table 3 Characterization of women with or without BV. Sociodemographic, medical, reproductive, behavioral and microbiological variables
among women with or without BV.
Variables BV positive (n= 8) BV negative (n= 198) p value OR 95%CI
Sociodemographic
Age (mean± SD, years) 32.00± 3.16 29.91± 5.21 0.14
<30 years 1 85 0.19 0.02–1.57
≥30 years 7 113 5.27 0.64–43.63
Educational level 0.97
≤Basic 2 58 0.81 0.16–4.11
Secondary 3 70 1.10 0.26–4.73
≥University 3 70 1.10 0.26–4.73
Medical
Previous BV 2 14 0.12 4.38 0.81–23.75
History of chronic disease 3 27 0.09 3.80 0.86–16.83
Reproductive
Previous delivery 4 82 0.72 1.42 0.34–5.82
Previous preterm delivery 2 12 0.09 5.17 0.94–28.39
Pregnancy trimester 0.27
First 2 22 2.67 0.51–14.04
Second 0 34 0.28 0.02–4.98
Third 6 142 1.18 0.23–6.04
Behavioral
Tobacco consumption 0 26 0.60 0.38 0.02–6.84
Use of intimate hygiene products 4 55 0.23 2.60 0.63–10.76
Vitamin supplementation 7 171 1.00 1.11 0.13–9.35
Microbiological
G. vaginalis presence 8 131 0.06 8.73 0.50–153.60
Notes.
BV, bacterial vaginosis; OR, odds ratio; CI, confidence interval; SD, standard deviation.
Values are given as mean± SD or number.
Vaginal colonization by G. vaginalis was detected in 139 samples, representing a
prevalence rate of 67.48% (Table 4). Statistically significant differences betweenG. vaginalis
positive and negative groups were found in relation to maternal educational level, current
pregnancy trimester and vaginal microflora profile (p value < 0.05). Of note is that basic
educational level (OR = 2.77, 95% CI [1.33–5.78]), second pregnancy trimester (OR =
6.12, 95% CI [1.80–20.85]) and presence of BV flora (OR = 8.73, 95% CI [0.50–153.60])
were associated with higher rates of G. vaginalis colonization in these pregnant women.
DISCUSSION
This is the first epidemiological study conducted in Portugal with the aim to assess the preva-
lence of BV among pregnantwomen, as well as to identify risk factors for BV andG. vaginalis
colonization during pregnancy. In contrast with the high frequency of G. vaginalis, BV
was diagnosed in only 3.88% of studied population. This BV prevalence rate is much
lower than that reported by other Portuguese studies (Guerreiro, Gigante & Teles, 1998;
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Table 4 Characterization of women with or without vaginal colonization byG. vaginalis. Sociodemographic, medical, reproductive, behavioral
and microbiological variables among women with or without G. vaginalis colonization.
Variables GV positive (n= 139) GV negative (n= 67) p value OR 95%CI
Sociodemographic
Age (mean± SD, years) 29.94± 5.35 30.12± 4.78 0.88
<30 years 59 27 1.09 0.60–1.98
≥30 years 80 40 0.92 0.51–1.66
Educational level 0.02
≤Basic 49 11 2.77 1.33–5.78
Secondary 47 26 0.81 0.44–1.47
≥University 43 30 0.55 0.30–1.01
Medical
Previous BV 13 3 0.28 2.20 0.61–8.01
History of chronic disease 24 6 0.14 2.12 0.82–5.47
Reproductive
Previous delivery 62 24 0.29 1.44 0.79–2.63
Previous preterm delivery 9 5 0.77 0.86 0.28–2.67
Pregnancy trimester <0.01
First 17 7 1.19 0.47–3.04
Second 31 3 6.12 1.80–20.85
Third 91 57 0.33 0.16–0.71
Behavioral
Tobacco consumption 22 4 0.07 2.96 0.98–8.98
Use of intimate hygiene products 45 14 0.10 1.81 0.91–3.61
Vitamin supplementation 124 54 0.13 1.99 0.89–4.47
Microbiological 0.02
Normal flora 94 56 0.41 0.20–0.86
Intermediate flora 37 11 1.85 0.87–3.90
BV flora 8 0 8.73 0.50–153.60
Notes.
GV, Gardnerella vaginalis; OR, odds ratio; CI, confidence interval; SD, standard deviation; BV, bacterial vaginosis.
Values are given as mean± SD or number.
Machado et al., 2015). Indeed, Guerreiro, Gigante & Teles (1998) detected a BV prevalence
of 7% among 840 contraceptive users living in Lisbon region while Machado et al. (2015)
found a BV rate of 17.33%, among 150 young Portuguese women. Despite the lower cases
of pregnant women with BV reported in this study, our results were consistent with other
European studies. Cristiano et al. (1996) described a BV prevalence rate of 4.9% in 1,441
Italian pregnant women while Gratacós and co-workers (1999) found BV in 4.5% among
492 Spanish women with low risk pregnancies. Akinbiyi and colleagues (2008) conducted a
randomized prospective study to determine the prevalence and age distribution of Candida
albicans and BV among English pregnant women, and found a BV prevalence of 3.54%
(38/1073) with the majority of BV cases belonging to the age group of 21–30 years.
Contrasting with the very low prevalence of BV, in our study population, we found a G.
vaginalis colonization rate of 67.48%. A significant higher colonization by G. vaginalis not
associated to BV has been reported elsewhere (Cox et al., 2016; Janulaitiene et al., 2017).
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However, other epidemiological studies reported G. vaginalis colonization rates much
lower than ours (Pépin et al., 2011; Schwebke, Flynn & Rivers, 2014; Silva et al., 2014).
These differences might be the result of significant different populations at study. In fact,
recent genomic studies described that vaginal microbiome in pregnancy is unique and
distinct of the non-pregnant women (Aagaard et al., 2012; Jespers et al., 2015).
The observation that G. vaginalis colonization is not sufficient to cause BV, is not
new (Aroutcheva et al., 2001; Fredricks et al., 2007; Menard et al., 2008). However, recent
genomic studies have highlighted that G. vaginalis found in healthy women have distinct
genetic profiles than isolates from women with BV (Schellenberg et al., 2016; Janulaitiene et
al., 2017). Interestingly, it has been proposed that some of the knownG. vaginalis genotypes
are, in fact, distinct species (Cerca et al., 2017). This is supported by full genome sequence
analysis and microbiology functional studies (Harwich et al., 2010; Yeoman et al., 2010;
Castro et al., 2015).
CONCLUSIONS
For the first time, BV andG. vaginalis prevalence among Portuguese pregnant women were
determined. We found that BV prevalence was low but G. vaginalis colonization was very
high. Importantly, due to the small sample size, associations between BV and potential risk
factors should be made with caution and as such, further studies involving a large number
of participants and in different regions of the country should be performed in the future,
to confirm our observations.
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